United States Breast Cancer Screening Market Analysis By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies And Forecast 2017 To 2022

1. Executive Summary

2. Breast Cancer Facts

3. United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010–2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death

4. Market Overview: United States Breast Cancer Screening (2010 – 2022)

5. Market Share: United States Breast Cancer Screening (2010 – 2022)

6. By Types: Market Size & Analysis (2010 – 2022)
6.1 Mammography Screening Market
6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
6.3 Breast Ultrasound Screening Market

7. Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
7.1 Market Drivers
7.2 Market Inhibitors

8. Reimbursement Policies of the United States Breast Cancer Screening
8.1 Mammography
8.2 Breast Magnetic Resonance Imaging(MRI)
8.3 Breast Ultrasound

9. Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2017
9.2 Year 2016
9.3 Year 2015

10. Key Manufacturers Analysis
10.1 Hologic
10.1.1 Business Overview
10.1.2 Breast Cancer Screening – Marketed Products
10.1.2.1 Mammography
10.1.2.2 Magnetic Resonance Imaging(MRI)
10.1.3 Breast Cancer Screening – Latest Development & Trends
10.2 Hitachi Medical Corporation
10.2.1 Business Overview
10.2.2 Breast Cancer Screening – Marketed Products
10.2.2.1 Magnetic Resonance Imaging(MRI)
10.2.2.2 Ultrasound
10.2.3 Breast Cancer Screening – Latest Development & Trends
10.3 Siemens Healthineers
10.3.1 Business Overview
10.3.2 Breast Cancer Screening – Marketed Products
10.3.2.1 Mammography
10.3.2.2 Magnetic Resonance Imaging (MRI)
10.3.3 Breast Cancer Screening – Latest Development & Trends
10.4 Philips Healthcare
10.4.1 Business Overview
10.4.2 Breast Cancer Screening – Marketed Products
10.4.2.1 Mammography
10.4.2.2 Magnetic Resonance Imaging (MRI)
10.4.2.3 Ultrasound
10.4.3 Breast Cancer Screening – Latest Development & Trends
10.5 Toshiba Medical Systems Corporation
10.5.1 Business Overview
10.5.2 Breast Cancer Screening – Marketed Products
10.5.2.1 Mammography
10.5.2.2 Magnetic Resonance Imaging (MRI)
10.5.2.3 Ultrasound
10.5.3 Breast Cancer Screening – Latest Development & Trends
10.6 GE Healthcare
10.6.1 Business Overview
10.6.2 Breast Cancer Screening – Marketed Products
10.6.2.1 Mammography
10.6.2.2 Magnetic Resonance Imaging (MRI)
10.6.2.3 Ultrasound
10.6.3 Breast Cancer Screening – Latest Development & Trends

Table 5–1: United States – Breast Cancer Screening Market Share(Percent),2010 – 2016
Table 5–2: United States – Forecast for Breast Cancer Screening Market Share(Percent),2017 – 2022
Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
Figure 4–1: United States – Breast Cancer Screening Market (Million US$),2010 – 2016
Figure 4–2: United States – Forecast for Breast Cancer Screening Market (Million US$),2017 – 2022
Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
Figure 6–3: United States – MRI Screening Market (Million US$),2010 – 2016
Figure 6–4: United States – Forecast for MRI Screening Market (Million US$),2017 – 2022
Figure 6–5: United States – Breast Ultrasound Screening Market (Million US$),2010 – 2016
Figure 6–6: United States – Breast Ultrasound Screening Market (Million US$),2017 – 2022

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.